MedTrace Logo

HPV Self-test to Increase Cervical Cancer Screening in Asian Women

NCT04612660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2022-09-30

No results posted yet for this study

Summary

The study was to pilot test the feability of using HPV self-sampling testing to increase cervical cancer screening among under-served Asian women through engaging community-based organizations in the greater Philadelphia and New York City area, addressing a significant global cancer burden, the preventable infection-related cervical cancer.

Conditions

Interventions

BEHAVIORAL

Education on cervical cancer prevetnion

Motivational group education by trained bilingual community health educators (CHEs) on cervical cancer prevention

BEHAVIORAL

Dynamic group interaction

Dynamic group interaction and role play discussion sessions on the benefits of Self-Sample collection HPV testing and procedures;

BEHAVIORAL

Physician engagement

Engaging community bilingual physicians in cervical cancer screening and referral;

BEHAVIORAL

Patient Navigation

Patient navigation assistance will be provided to participants who tested HPV positive for further diagnostic testing and treatment.

BEHAVIORAL

General Health Education

general health education focusing on healthy lifestyle, and prevention of disease through routine health examinations.

Sponsors & Collaborators

  • Temple University

    lead OTHER

Principal Investigators

  • Grace Ma, PhD · Temple University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04612660 on ClinicalTrials.gov